A new human breast cancer cell line, KPL-3C, secretes parathyroid hormone-related protein and produces tumours associated with microcalcifications in nude mice

British Journal of Cancer

Volumn 74, Issue 2, 1996, Pages 200-207

  Kurebayashi, J ^a   Kurosumi, M ^b   Sonoo, H ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b SAITAMA CANCER CENTER   (Japan)

Author keywords

Breast cancer; Cell line; Hypercalcaemia; Microcalcification; Parathyroid hormone related protein

Indexed keywords

22 OXACALCITRIOL; ESTROGEN RECEPTOR; HYDROCORTISONE; MEDROXYPROGESTERONE ACETATE; PARATHYROID HORMONE RELATED PROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROGESTERONE RECEPTOR;

ADULT; ANIMAL EXPERIMENT; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CASE REPORT; CELL STRUCTURE; CYTOGENETICS; FEMALE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNORADIOMETRIC ASSAY; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; TUMOR CALCINOSIS;

EID: 0030015979     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.338     Document Type: Article

References (46)

1. BELLAHCÈNE A, MERVILLE M-P AND CASTRONOVO V. (1994). Expression of bone sialoprotein, a bone matrix protein, in human breast cancer. Cancer Res., 54, 2823-2826.
2. BIRCH MA, CARRON JA, SCOTT M, FRASER WD AND GALLAGHER JA. (1995). Parathyroid hormone (PTH)/PTH-related protein (PTH-P) receptor expression and mitogenic responses in human breast cancer cell lines. Br. J. Cancer, 72, 90-95.
3. BODY JJ, BORKOWSKI A, CLEEREN A AND BIJVOET OLM. (1986). Treatment of malignancy-associated hypercalcemia with intravenous aminohydroxypropylidene diphosphate (APD). J. Clin. Oncol., 4, 1177-1183.
4. BODY JJ, MAGRITTE A, SERAJI F, SCULIER JP AND BORKOWSKI A. (1989). Aminohydroxypropylidene bisphosphonate (APD) treatment for tumor-associated hypercalcemia: a randomized comparison between a 3-day treatment and single 24-hour infusions. J. Bone Miner. Res., 4, 923-928.
5. BODY JJ, DUMON JC, THIRION M AND CLEEREN A. (1993). Circulating PTHrP concentrations in tumor-induced hypercalcemia: influence on the response to bisphosphonate and changes after therapy. J. Bone Miner. Res., 8, 701-706.
6. BOUIZAR Z, SPYRATOS F, DEYTIEUX S, DE VERNEJOUL M-C AND JULLIENNE A. (1993). Polymerase chain reaction analysis of parathyroid hormone-related protein gene expression in breast cancer patients and occurrence of bone metastasis. Cancer Res., 53, 5076-5078.
7. BUNDRED NJ, WALKER RA, RATCLIFFE WA, WARWICK J, MORRISON JM AND RATCLIFFE JG. (1992). Parathyroid hormone related protein and skeletal morbidity in breast cancer. Eur. J. Cancer., 28, 690-692.
8. BURTIS WJ, BRADY TG, ORLOFF JJ, ERSBAK JB, WARRELL RP, OLSON BR, WU TL, MITNICK ME, BROADUS AE AND STEWART AF. (1990). Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer. N. Engl. J. Med., 322, 1106-1112.
9. DEFTOS LJ, GAZDAR AF AND BROADUS AE. (1989). The parathyroid hormone-related protein associated with malignancy is secreted by neuroendocrine tumors. Mol. Endocrinol., 3, 503-508.
10. DE LAFONTAN B, DAURES JP, SALICRU B, EYNIUS F, MIHURA J, ROUANET P, LAMARQUE JL, NAJA A AND PUJOL H. (1994). Isolated clustered microcalcifications: diagnostic value of mammography - series of 400 cases with surgical verification. Radiology, 190, 479-483.
11. DE MIGUEL F AND ESBRIT P. (1992). Isolation of a 18000-Da molecular weight form of parathyroid hormone-related protein from the rat Walker carcinosarcoma 256. Cancer Lett., 66, 201-206.
12. DUMON JC, MAGRITTE A AND BODY JJ. (1991). Efficacy and safety of the bisphosphonate tiludronate for the treatment of tumor-associated hypercalcemia. Bone Miner., 15, 257-266.
13. EGAN RL, SWEENEY MB AND SEWELL C. (1980). Intramammary calcifications without an associated mass in benign and malignant diseases. Radiology, 137, 1-7.
14. ELLISON M, WOODHOUSE D, HILLYARD CJ, DOWSETT R, COOMBES C, GILBY ED, GREENBERG PB AND NEVILLE AM. (1975). Immunoreactive calcitonin production by human lung carcinoma cells in culture. Br. J. Cancer, 32, 373-379.
15. GRILL V, HO P, MOSELEY JM, JOHNASON N, LEE S, BODY JJ, KUKREJA S AND MARTIN TJ. (1991). Parathyroid hormone-related protein: elevated levels both in humoral hypercalcemia of malignancy and in hypercalcemia complicating metastatic breast cancer. J. Clin. Endocrinol. Metab., 73, 1309-1315.
16. HENDERSON J, SEBAG M, RHIM J, GOLTZMAN D AND KREMER R. (1991). Dysregulation of parathyroid hormone-like peptide expression and secretion in a keratinocyte model of tumor progression. Cancer Res., 51, 6521-6528.
17. ICHINOSE Y, IGUCHI H, OHTA M AND KATAKAMI H. (1993). Establishment of lung cancer cell line producing parathyroid hormone-related protein. Cancer Lett., 74, 119-124.
18. IKEDA K, OHNO H, HANE M, YOKOI H, OKADA M, HONMA T, YAMADA A, TATSUMI Y, TANAKA T, SAITOH T, HIROSE S, MORI S, TAKEUCHI Y, FUKUMOTO S, TERUKINA S, IGUCHI H, KIRIYAMA T, OGATA E AND MATSUMOTO T. (1994). Development of a sensitive two-site immunoradiometric assay for parathyroid hormone-related peptide: evidence for elevated levels in plasma from patients with adult T-cell leukemia/ lymphoma and B-cell lymphoma. J. Clin. Endocrinol. Metab., 79, 1322-1327.
19. INOUE D, MATSUMOTO T, OGATA E AND IKEDA K. (1993). 22-oxacalcitriol, a noncalcemic analogue of calcitriol, suppresses both cell proliferation and parathyroid hormone-related peptide gene expression in human T cell lymphotrophic virus, type I-infected T cell. J. Biol. Chem., 268, 19730-16736.
20. KANBARA Y, KONE N, NAKAYA M, ISHIKAWA Y, FUJIMOTO O, KANAZAWA R AND KITAZAWA S. (1993). Immunohistological evaluation of parathyroid hormone-related protein in breast cancer with and without calcification on mammography. J. Jpn. Surg. Soc., 94, 394-399. (in Japanese).
21. KITAZAWA S, FUKASE M, KITAZAWA R, TAKENAKA A, GOTOH A, FUJITA T AND MAEDA S. (1991). Immunohistological evaluation of parathyroid hormone-related protein in human lung cancer and normal tissue with newly developed monoclonal antibody. Cancer, 67, 984-989.
22. KOHNO N, KITAZAWA S, SAKODA Y, KANBARA Y, FURUYA Y, OHHASHI O AND KITAZAWA R. (1994a). Parathyroid hormone-related protein in breast cancer tissues: relationship between primary and metastatic sites. Breast Cancer, 1, 43-49.
23. KOHNO N, KITAZAWA S, FUKUSE M, SAKODA Y, KANBARA Y, FURUYA Y, OHASHI O, ISHIKAWA Y AND SAITOH Y. (1994b). The expression of parathyroid hormone-related protein in human breast cancer with skeletal metastases. Surg. Today, 24, 215-220.
24. KREMER R, KARAPLIS AC, HENDERSON J, GULLIVER W, BANVILLE D, HENDY GN AND GOLTZMAN D. (1991). Regulation of parathyroid hormone-like peptide in cultured normal human keratinocytes. J. Clin. Invest., 87, 884-893.
25. KUREBAYASHI J, MCLESKEY SW, JOHNSON MD, LIPPMAN ME, DICKSON RB, AND KERN FG. (1993). Quantitative demonstration of spontaneous metastasis by MCF-7 human breast cancer cells cotransfected with fibroblast growth factor 4 and lacZ. Cancer Res., 53, 2178-2187.
26. KUREBAYASHI J, KUROSUMI M AND SONOO H. (1995). A new human breast cancer cell line, KPL-1, secretes tumour-associated antigens and grows rapidly in female athymic nude mice. Br. J. Cancer, 71, 845-853.
27. MANGIN M, WEBB AC, DREYER BE, POSILLICO JT, IKEDA K, WEIR EC, STEWART AF, BANDER NH, MILSTONE L, BARTON DE, FRANCKE U AND BROADUS AE. (1988). Identification of a cDNA encoding a parathyroid hormone-like peptide from a human tumor associated with humoral hypercalcemia of malignancy. Proc. Natl Acad. Sci. USA, 85, 597-601.
28. MARTIN TJ. (1988). Humoral hypercalcemia of malignancy. Bone Miner., 4, 83-89.
29. MERRYMAN JI, ROSOL TJ, BROOKS CL AND CAPEN CC. (1989). Separation of parathyroid hormone-like activity from transforming growth factor-α and -β in the canine adenocarcinoma (CAC-8) model of humoral hypercalcemia of malignancy. Endocrinology, 124, 2456-2463.
30. MIYAKE Y, YAMAGUCHI K, HONDA S, NAGASAKI K, TSUCHIHASHI T, MORI M, KIMURA S AND ABE K. (1991). Production of parathyroid hormone-related protein in tumour xenografts in nude mice presenting with hypercalcemia. Br. J. Cancer, 63, 252-256.
31. MUNDY GR. (1990). Pathophysiology of cancer-associated hypercalcemia. Semin. Oncol., 17, 10-15.
32. MOLL R, FRANKE WW, SCHILLER DL, GEIGER B AND KREPLER R. (1982). The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors, and cultured cells. Cell, 31, 11-24.
33. POWELL GJ, SOUTHBY J, DANKS JA, STILLWELL RG, HAYMAN JA, HENDERSON MA, BENNETT RC AND MARTIN TJ. (1991). Localization of parathyroid hormone-related protein in breast cancer metastases: increased incidence in bone compared with other sites. Cancer Res., 51, 3059-3061.
34. RATCLIFFE WA, HUTCHESSON ACJ, BUNDRED NJ AND RATCLIFFE JG. (1992). Role of assays for parathyroid-hormone-related protein in investigation of hypercalcemia. Lancet, 339, 164-167.
35. SATO K, FUJI Y, ONO M, NOMURA H AND SHIZUME K. (1987). Production of interleukin 1α-like factor and colony-stimulating factor by a squamous cell carcinoma of the thyroid (T3M-5) derived from a patient with hypercalcemia and leucocytosis. Cancer Res., 47, 6474-6480.
36. SEBAG M, HENDERSON J, GOLTZMAN AND KREMER R. (1994). Regulation of parathyroid hormone-related peptide production in normal human mammary epithelial cells in vitro. Am. J. Physiol., 267, C723-C730.
37. SICKLES EA. (1986). Breast calcifications: mammographic evaluation. Radiology, 160, 289-293.
38. SKINNER MA, SWAIN M, SIMMONS R, MCCARTY KS, SULLIVAN DC AND IGLEHART JD. (1988). Nonpalpable breast lesions at biopsy: a detailed analysis of radiographic features. Ann. Surg., 208, 203-208.
39. SNYDER R AND ROSEN P. (1971). Radiography of breast specimens. Cancer, 28, 1608.
40. SOULE HD, VAZQUEZ J, LONG A, ALBERT S AND BRENNAN M. (1973). A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl Cancer Inst., 51, 1409-1416.
41. SOUTHBY J, KISSIN MW, DANKS JA, HAYMAN JA, MOSELEY JM, HENDERSON MA, BENNETT RC AND MARTIN TJ. (1990). Immunohistochemical localization of parathyroid hormone-related protein in human breast cancer. Cancer Res., 50, 7710-7716.
42. STREWLER GJ, WILLIAMS RD AND NISSENSON RA. (1983). Human renal carcinoma cells produce hypercalcemia in the nude mouse and a novel protein recognized by parathyroid hormone receptors. J. Clin. Invest., 71, 769-774.
43. SUVA LJ, WINSLOW GA, WETTENHALL REH, HAMMONDS RG, MOSELEY JM, DIEFENBACH-JAGGER H, RODDA CP, KEMP PE, RODRIGEZ H, CHEN EY, HUDSON PJ, MARTIN TJ AND WOOD WI. (1987). A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science, 237, 893-896.
44. TABUENCA A, MOHAN S, GARBEROGLIO CA, BORGEN PI, ROSOL T AND LINKHART TA. (1995). Parathyroid hormone-related protein: primary osteolytic factor produced by breast cancer cells in vitro. World J. Surg., 19, 292-298.
45. VARGUS SJ, GILLESPIE MT, POWELL GJ, SOUTHBY J, DANKS JA, MOSELEY JM AND MARTIN YJ. (1992). Localization of parathyroid hormone-related protein mRNA expression in breast cancer and metastatic lesions by in situ hybridization. J. Bone Miner. Res., 7, 971-979.
46. WALLS J, RATCLIFFE WA, HOWELL A AND BUNDRED NJ. (1994). Response to intravenous bisphosphonate therapy in hypercalcemic patients with and without bone metastasis: the role of parathyroid hormone-related protein. Br. J. Cancer, 70, 169-172.